Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Net Cash Flow (2016 - 2021)

Historic Net Cash Flow for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$2.3 million.

  • ENDRA Life Sciences' Net Cash Flow fell 16789.85% to -$2.3 million in Q4 2021 from the same period last year, while for Dec 2021 it was $2.2 million, marking a year-over-year increase of 11215.45%. This contributed to the annual value of $395574.0 for FY2024, which is 11924.76% up from last year.
  • ENDRA Life Sciences' Net Cash Flow amounted to -$2.3 million in Q4 2021, which was down 16789.85% from -$2.3 million recorded in Q3 2021.
  • In the past 5 years, ENDRA Life Sciences' Net Cash Flow registered a high of $9.6 million during Q1 2021, and its lowest value of -$3.1 million during Q1 2020.
  • Moreover, its 5-year median value for Net Cash Flow was -$1.2 million (2017), whereas its average is $465829.0.
  • As far as peak fluctuations go, ENDRA Life Sciences' Net Cash Flow plummeted by 2164818.17% in 2018, and later soared by 3907565.62% in 2020.
  • ENDRA Life Sciences' Net Cash Flow (Quarter) stood at -$1.4 million in 2017, then skyrocketed by 524.13% to $5.8 million in 2018, then tumbled by 33.17% to $3.9 million in 2019, then fell by 11.92% to $3.4 million in 2020, then crashed by 167.9% to -$2.3 million in 2021.
  • Its last three reported values are -$2.3 million in Q4 2021, -$2.3 million for Q3 2021, and -$2.8 million during Q2 2021.